Windtree Therapeutics has announced plans to acquire up to $700 million in BNB, following the coin's recent all-time high price of $808. The Nasdaq-listed biotech firm aims to bolster its balance sheet with this digital asset and has secured up to $520 million in funding from an institutional investor to facilitate these purchases. Additionally, Windtree has partnered with Kraken, a prominent cryptocurrency exchange, for custody and trading services related to BNB. Windtree's commitment to purchasing BNB reflects a broader trend among publicly traded companies investing in crypto assets to boost their stock values. This month, the firm’s stock has seen a remarkable 162% increase, although it experienced a 5% decline on the day of the announcement. BNB, which has a market cap of $106.9 billion, operates on the BNB Chain, originally developed by Binance in 2017 as a marketplace currency. Windtree's strategy is part of a wave of companies seeking to establish crypto treasuries, with similar moves by other firms in the sector.

Source 🔗